Osmind is the premier platform for clinicians and researchers advancing new life-saving mental health treatments. Today, mental health disorders are one of the leading causes of death worldwide, especially among young adults, and are tied to shortening lifespans. While there have been developments in new psychiatric medications since the first FDA approval in 1954, today there is a growing movement among clinicians, patients, and researchers who are recognizing the need to accelerate new science. The Osmind treatment platform is the first and only solution that solves specific challenges faced by neuropsychiatric clinics, spanning general psychiatry and interventional psychiatry (transcranial magnetic stimulation, ketamine, SPRAVATO®, psychedelic medicine, electroconvulsive therapy). The core electronic health record (EHR) technology is precisely developed for interventional treatment workflows and designed to support a strong therapeutic alliance, including journaling tools and assistance with health plan reimbursement, which is a significant access hurdle for millions of patients. Research from our platform is already helping to set new standards for mental health interventions. For example, in the largest published real-world analysis of ketamine infusion therapy for depression, we teamed up with Stanford University School of Medicine to share findings in the Journal of Affective Disorders (March 2022). We have multiple ongoing research studies leveraging our proprietary real-world data, including an even larger ketamine analysis leveraging machine learning to predict treatment outcomes. Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists. We are backed by top investors including DFJ Growth, General Catalyst, Future Ventures, Tiger Global, and Y Combinator.
Osmind is the premier technology platform for mental health treatment and research, designed to optimize workflows, enhance patient engagement, and advance evidence-based medicine.
Osmind offers flexible pricing plans tailored to the needs of various mental health practices. Contact us for detailed pricing information and to find the plan that best suits your practice.
Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists. Our mission is to advance new evidence-based medicine for people living with moderate to severe mental health conditions. Join our forward-thinking team and be part of the future of mental health care.
AI-supported M&A Intelligence for BioPharma
Next-generation psychedelic therapeutics for mental health
Empowering every doctor and every patient to participate in research
AI-Powered Clinical Decision Support
Hypnosis-based digital therapeutics for chronic conditions like IBS…
AI platform accelerating therapies for rare & inflammatory diseases.
We use human data and AI to develop better drugs faster.
Empowering Patients for Deep Real World Data
Precision mental health care for women
Bunkerhill Health is the commercialization engine for healthcare AI
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS